Response is muted, thus far.
Have not run the numbers yet, but if 'double digit' growth was worth $28, then how can 5.6% be worth $15? Is the 5% difference really worth that much?
If so, then the close to 10% for the year should allow the SP to rise considerably, with or without trial data, or R&D stuff?
At current price I change my sentiment back to Buy.
Ann: First Half Worldwide Dose Sales Growth of 5.6%, page-7
-
- There are more pages in this discussion • 311 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.005(2.70%) |
Mkt cap ! $80.64M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 19.5¢ | 18.5¢ | $270.4K | 1.424M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 2502457 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.0¢ | 519251 | 7 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| SRX (ASX) Chart |